美鼎生物(VIVO)
33.97 0.00 0.0%
| 今开：0.0 | 昨收：33.97 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.494957161E9 |
美鼎生物的最新讨论
![[哭泣]](http://js.xueqiu.com/ugc/images/face/emoji_09_cry.png?v=1 "[哭泣]"){kind=small}
用户28964502982022-07-08 16:40
$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文
牛唐2022-07-08 15:08
韩国SD Biosensor和SJL Partners (Consortium)以15.3亿美元全现金收购$美鼎生物(VIVO)$ 。
$东方生物(SH688298)$ $金域医学(SH603882)$查看全文
美鼎生物的公告
$Meridian Bioscience(VIVO)$ 美东时间 2013-05-20 09:30 Meridian Bioscience, Inc. at UBS Global Healthcare Conference
$Meridian Bioscience(VIVO)$ 美东时间 2013-05-15 19:20 Meridian Bioscience, Inc. at Bank of America Merrill Lynch Health Care Conference
$Meridian Bioscience(VIVO)$ 美东时间 2013-05-09 12:30 Meridian Bioscience, Inc. at Robert W Baird and Co Growth Stock Conference
内部交易: $Meridian Bioscience(VIVO)$ 2013-05-01,CEO,KRAEUTLER JOHN A ,买入,5000普通股, $19.63
内部交易: $Meridian Bioscience(VIVO)$ 2013-03-11,Director,READY ROBERT J ,卖出,5000普通股, $21.69
内部交易: $Meridian Bioscience(VIVO)$ 2013-03-05,执行Chairman,MOTTO WILLIAM J ,卖出,2500普通股, $21.59
内部交易: $Meridian Bioscience(VIVO)$ 2012-12-14,Exec VP, CFO,LUEKE MELISSA ,卖出,15750普通股, $19.83
内部交易: $Meridian Bioscience(VIVO)$ 2012-12-13,Exec VP, CFO,LUEKE MELISSA ,卖出,5250普通股, $19.88
内部交易: $Meridian Bioscience(VIVO)$ 2012-12-13,Exec VP, CFO,LUEKE MELISSA ,期权,21000普通股, $0.00
内部交易: $Meridian Bioscience(VIVO)$ 2012-12-11,EVP,Pres Meridian Life Science,EBERLY RICHARD ,卖出,31500普通股, $20.47